Featured Research

from universities, journals, and other organizations

New Ways Identified To Treat 'Lazy Eye' In Children: Beyond Eye Patches And Daily Drops

Date:
November 5, 2004
Source:
Saint Louis University
Summary:
New research suggests a way to treat "lazy eye" that may be easier on children--and their parents--than current treatments.

ST. LOUIS -- New research suggests a way to treat "lazy eye" that may be easier on children--and their parents--than current treatments.

Researchers at Saint Louis University and other institutions have found that atropine eye drops administered two days a week are as effective at treating amblyopia, or "lazy eye," as daily drops or an eye patch. The research was published today in the journal Ophthalmology.

"As anyone who has given eye drops to a child knows, this is good news," said Oscar Cruz, M.D., chairman of the department of ophthalmology at Saint Louis University and a researcher in the study. "It makes it much less of a hassle to administer the medicine, which is crucial for young patients to develop healthy vision."

Amblyopia occurs when the brain favors one eye over the other. The condition can be corrected by temporarily impairing vision in the "strong" eye, forcing the weak eye to work harder to compensate. This traditionally has been accomplished when a child wears an eye patch over the strong eye.

An earlier study by the same research group, known as the Pediatric Eye Disease Investigator Group (PEDIG), found that daily doses of atropine drops, which dilate the eye and blur vision, were as effective as an eye patch. Another study by the group found that eye patches could be effective when worn for only two hours a day, rather than six hours.

The combined body of research should enable doctors to make better decisions about treatment for their patients, Dr. Cruz said.

"A treatment that is tolerated well by one child won't necessarily be tolerated well by another," he said. "It's important for families and their physicians to have a range of effective treatment options."

In the most recent study, 168 children younger than 7 years old with moderate amblyopia were randomly assigned to receive either weekend or daily atropine. Patients in both groups showed substantial improvement in the eye with amblyopia. After four months, 72 percent of children in the weekend group and 73 percent of the patients in the daily group could read at least two more lines on the standard eye chart.

Bradley Davitt, M.D., associate professor of ophthalmology at Saint Louis University also participated in the research.

###

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.


Story Source:

The above story is based on materials provided by Saint Louis University. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University. "New Ways Identified To Treat 'Lazy Eye' In Children: Beyond Eye Patches And Daily Drops." ScienceDaily. ScienceDaily, 5 November 2004. <www.sciencedaily.com/releases/2004/11/041104010954.htm>.
Saint Louis University. (2004, November 5). New Ways Identified To Treat 'Lazy Eye' In Children: Beyond Eye Patches And Daily Drops. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2004/11/041104010954.htm
Saint Louis University. "New Ways Identified To Treat 'Lazy Eye' In Children: Beyond Eye Patches And Daily Drops." ScienceDaily. www.sciencedaily.com/releases/2004/11/041104010954.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins